Now I have comprehensive information from multiple authoritative sources. Let me compile a thorough answer.
Preoxygenation with High-Flow Nasal Oxygen (HFNO/HFNC)
Physiological Basis of Preoxygenation
Preoxygenation replaces nitrogen in the lungs with oxygen, converting the lungs into an oxygen reservoir during the apneic period of rapid-sequence intubation (RSI). The goal is denitrogenation — not simply achieving SpO₂ 100%, since an SpO₂ of 100% can correspond to a PaO₂ anywhere from ~100 to 600 mmHg.
With maximal preoxygenation, safe apnea time before oxyhemoglobin desaturation to <80% ranges:
- Healthy non-obese adult: ~9 minutes
- Obese adults / children: ≤3 minutes
Those at greatest risk for rapid desaturation: obese, pregnant, critically ill, and pediatric patients.
— Roberts and Hedges' Clinical Procedures in Emergency Medicine; Miller's Anesthesia, 10e
Standard Preoxygenation Techniques
| Method | Details |
|---|
| Tidal volume breathing | 3–5 min via face mask, achieves exchange of ~95% lung gas; preferred |
| Vital capacity breaths | 8 breaths over 60 s (4 breaths/30 s less effective); for time-limited scenarios |
| End-tidal O₂ target | Continue until EtO₂ ≥90% |
Flow rate is critical: FiO₂ delivered by any mask device is inadequate at <30 L/min. The flowmeter should be turned to flush rate (typically >40 L/min; up to 70–90 L/min on some flowmeters). High-flow oxygen washes out CO₂ from dead space, fills the nasopharynx with O₂, compensates for mask leaks, and generates 1–2 cmH₂O of passive CPAP.
— Roberts and Hedges'
HFNC for Preoxygenation
High-flow nasal cannula (HFNC) delivers warmed, humidified oxygen at 30–70 L/min (sometimes called THRIVE — Transnasal Humidified Rapid-Insufflation Ventilatory Exchange at 60 L/min).
Mechanisms of benefit
- High FiO₂ delivery — eliminates nasopharyngeal dead space nitrogen, delivers near-100% FiO₂
- Low-level PEEP (~1–3 cmH₂O) — reduces atelectasis, preserves FRC
- CO₂ washout from upper airway — delays hypercapnia during apnea
- Continuous flow during apnea — enables simultaneous apneic oxygenation without interruption
THRIVE evidence (Miller's Anesthesia, 10e)
THRIVE at 60 L/min for 3 minutes is as effective as tidal-volume preoxygenation by face mask. In 25 patients with anticipated difficult airways, THRIVE extended safe apnea time significantly beyond standard techniques, preventing the development of severe respiratory acidosis.
— Miller's Anesthesia, 10e
When to use HFNC for preoxygenation
| Clinical Context | Recommendation |
|---|
| Mild hypoxemia (P/F >200–300) | HFNC is a reasonable alternative to face mask |
| Moderate–severe hypoxemia (P/F <200) | NIV preferred over HFNC — fewer severe hypoxemic events (FLORALI-2 trial) |
| Cooperative patient, elective intubation | HFNC ± face mask acceptable |
| Uncooperative/agitated patient | HFNC may be preferred due to tolerability |
| Obese patient | HFNC + head-up position (25° or ramped); delays desaturation |
"Current evidence does not support the use of HFNC for preoxygenation before intubation as the sole modality. HFNC should be considered for mild hypoxemia; NIV used for more severe cases."
— Murray & Nadel's Textbook of Respiratory Medicine
HFNC as Apneic Oxygenation (During Intubation)
Even after preoxygenation ends and laryngoscopy begins, HFNC left in situ provides apneic oxygenation via mass-flow oxygen delivery to the alveoli — exploiting the fact that O₂ diffuses across alveoli far faster than CO₂ is produced, creating a net pressure gradient that pulls O₂ distally.
- HFNC shown superior to simple nasal cannula for apneic oxygenation in ICU studies, though both had low hypoxemia rates
- For standard apneic oxygenation: nasal cannula at 15 L/min placed under the face mask during preoxygenation, then maintained throughout intubation
- HFNC provides higher and more consistent FiO₂ than simple cannula at equivalent flows, and the humidification prevents mucosal desiccation
— Roberts and Hedges' Clinical Procedures in Emergency Medicine, p. 113–114
Key Clinical Evidence
| Trial/Study | Finding |
|---|
| PREOXYFLOW (RCT, n=124; P/F <300) | No difference HFNC vs. face mask in SpO₂, adverse events, or ventilator-free days |
| FLORALI-2 (RCT, n=313; P/F ≤300) | No overall outcome difference HFNC vs. NIV; NIV fewer severe hypoxemic events in P/F <200 subgroup |
| PROTRACH (RCT, n=192; RSI) | HFNC vs. bag-valve mask: fewer desaturations <95% (12% vs. 23%, P=0.045) and fewer peri-intubation complications (6% vs. 19%, P=0.007) |
| THRIVE (observational) | 60 L/min HFNC = tidal volume face mask preoxygenation; extended apnea time |
Recent systematic review (2024): Crístian de Carvalho et al., Br J Anaesth (PMID: 38599916) — network meta-analysis of preoxygenation strategies.
Positioning
Head-up 20–25° (reverse Trendelenburg if spinal precautions needed) improves preoxygenation quality in both obese and non-obese adults by:
- Reducing abdominal pressure on the diaphragm
- Minimizing atelectasis formation
- Increasing FRC
Practical Protocol Summary
- Position: Head-up 20–25°
- Device: Non-rebreather mask at flush rate (≥40 L/min) or HFNC at 40–60 L/min
- Duration: 3–5 min tidal breathing (or 8 vital capacity breaths if time-critical)
- Augment: Place nasal cannula (15 L/min) or leave HFNC in place underneath the mask
- Target: EtO₂ ≥90% if measurable; SpO₂ + adequate time if not
- Severe hypoxemia (P/F <200): Add NIV/BiPAP for preoxygenation; HFNC alone insufficient
- Apneic phase: Keep HFNC or nasal cannula at 15 L/min throughout laryngoscopy
Sources: Roberts and Hedges' Clinical Procedures in Emergency Medicine | Miller's Anesthesia 10e | Murray & Nadel's Textbook of Respiratory Medicine | Barash Clinical Anesthesia 9e | PMID: 38599916 (network meta-analysis, 2024)